Emily M. Leproust - Nov 15, 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
President & CEO, Director
Signature
/s/ William Solis, as Attorney-in-Fact for Emily M. Leproust
Stock symbol
TWST
Transactions as of
Nov 15, 2021
Transactions value $
-$1,142,046
Form type
4
Date filed
11/17/2021, 03:35 PM
Previous filing
Nov 8, 2021
Next filing
Nov 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $62.1K +10.4K +6.18% $5.95 179K Nov 15, 2021 Direct
transaction TWST Common Stock Sale -$432K -3.76K -2.1% $114.73* 176K Nov 15, 2021 Direct F1, F2
transaction TWST Common Stock Sale -$772K -6.68K -3.8% $115.68* 169K Nov 15, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -10.4K -19.59% $0.00 42.9K Nov 15, 2021 Common Stock 10.4K $5.95 Direct F7
holding TWST Employee Stock Option (right to buy) 267K Nov 15, 2021 Common Stock 0 $26.66 Direct F4
holding TWST Employee Stock Option (right to buy) 131K Nov 15, 2021 Common Stock 0 $23.33 Direct F5
holding TWST Employee Stock Option (right to buy) 163K Nov 15, 2021 Common Stock 0 $8.82 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 28, 2021.
F2 Represents the weighted average sales price per share. The shares sold at prices ranging from $114.10 to $115.06 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3 Represents the weighted average sales price per share. The shares sold at prices ranging from $115.27 to $116.11 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F4 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F5 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F6 The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F7 The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.